Constant V.M. Verschuur

445 total citations
11 papers, 267 citations indexed

About

Constant V.M. Verschuur is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Constant V.M. Verschuur has authored 11 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Cognitive Neuroscience. Recurrent topics in Constant V.M. Verschuur's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (7 papers) and Autism Spectrum Disorder Research (3 papers). Constant V.M. Verschuur is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (7 papers) and Autism Spectrum Disorder Research (3 papers). Constant V.M. Verschuur collaborates with scholars based in Netherlands, Canada and United States. Constant V.M. Verschuur's co-authors include Sven R. Suwijn, Rob M.A. de Bie, Anthony E. Lang, Teus van Laar, Bart Post, Rob J. de Haan, Gerrit Tissingh, Günther Deuschl, Marcel G. W. Dijkgraaf and Judith A. Boel and has published in prestigious journals such as New England Journal of Medicine, Neurology and Scientific Reports.

In The Last Decade

Constant V.M. Verschuur

11 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Constant V.M. Verschuur Netherlands	7	223	95	38	22	18	11	267
Sven R. Suwijn Netherlands	9	304 1.4×	123 1.3×	46 1.2×	39 1.8×	24 1.3×	13	376
Anna Hotter Austria	6	213 1.0×	59 0.6×	31 0.8×	19 0.9×	30 1.7×	12	262
Silvia Ríos‐Romenets Colombia	5	155 0.7×	46 0.5×	26 0.7×	28 1.3×	40 2.2×	9	221
Shengri Cong China	4	116 0.5×	41 0.4×	23 0.6×	22 1.0×	26 1.4×	4	156
Toby C. Yaltho United States	9	324 1.5×	118 1.2×	32 0.8×	23 1.0×	16 0.9×	10	389
Vladimír Haň Slovakia	9	216 1.0×	65 0.7×	16 0.4×	23 1.0×	15 0.8×	16	266
Reed Johnson United States	10	298 1.3×	128 1.3×	57 1.5×	27 1.2×	7 0.4×	13	370
Melissa Gerstenhaber United States	3	119 0.5×	34 0.4×	32 0.8×	16 0.7×	12 0.7×	5	173
Gerard Saranza Canada	9	143 0.6×	77 0.8×	14 0.4×	29 1.3×	17 0.9×	23	210
Jeana Jaglin United States	4	132 0.6×	136 1.4×	30 0.8×	65 3.0×	14 0.8×	4	216

Countries citing papers authored by Constant V.M. Verschuur

Since Specialization

Citations

This map shows the geographic impact of Constant V.M. Verschuur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constant V.M. Verschuur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constant V.M. Verschuur more than expected).

Fields of papers citing papers by Constant V.M. Verschuur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constant V.M. Verschuur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constant V.M. Verschuur. The network helps show where Constant V.M. Verschuur may publish in the future.

Co-authorship network of co-authors of Constant V.M. Verschuur

This figure shows the co-authorship network connecting the top 25 collaborators of Constant V.M. Verschuur. A scholar is included among the top collaborators of Constant V.M. Verschuur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constant V.M. Verschuur. Constant V.M. Verschuur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Verschuur, Constant V.M., Sven R. Suwijn, Judith A. Boel, et al.. (2024). Long‐Term Follow‐Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson's Disease. Movement Disorders. 39(6). 975–982. 8 indexed citations

Horst, Liora ter, Ingeborg E. van Zeggeren, Björn M. van Geel, et al.. (2023). Predictors of unfavourable outcome in adults with suspected central nervous system infections: a prospective cohort study. Scientific Reports. 13(1). 21250–21250. 2 indexed citations

Zeggeren, Ingeborg E. van, Liora ter Horst, Björn M. van Geel, et al.. (2022). Seizures in adults with suspected central nervous system infection. BMC Neurology. 22(1). 426–426. 6 indexed citations

Verschuur, Constant V.M., Sven R. Suwijn, Rob J. de Haan, et al.. (2022). Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease. Journal of Parkinson s Disease. 12(7). 2171–2178. 2 indexed citations

Verschuur, Constant V.M., Sven R. Suwijn, Judith A. Boel, et al.. (2022). Levodopa Response in Patients With Early Parkinson Disease. Neurology. 100(4). e367–e376. 14 indexed citations

Suwijn, Sven R., Carsten Eggers, Alberto J. Espay, et al.. (2020). Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD). Journal of Parkinson s Disease. 10(4). 1561–1569. 6 indexed citations

Suwijn, Sven R., Constant V.M. Verschuur, Marleen A. Slim, Jan Booij, & Rob M.A. de Bie. (2019). Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease. EJNMMI Research. 9(1). 63–63. 8 indexed citations

Verschuur, Constant V.M., Sven R. Suwijn, Judith A. Boel, et al.. (2019). Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease. New England Journal of Medicine. 380(4). 315–324. 195 indexed citations

Verschuur, Constant V.M., Sven R. Suwijn, Bart Post, et al.. (2015). Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study. BMC Neurology. 15(1). 236–236. 11 indexed citations

10.

Suwijn, Sven R., Henk W. Berendse, Constant V.M. Verschuur, Rob M.A. de Bie, & Jan Booij. (2014). Serotonin Transporter Availability in Early Stage Parkinson’s Disease and Multiple System Atrophy. PubMed. 2014. 1–4. 5 indexed citations

11.

Suwijn, Sven R., Henk W. Berendse, Constant V.M. Verschuur, et al.. (2013). SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias. EJNMMI Research. 3(1). 44–44. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact